HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is the use of Ro 10-9359 (Tigason) in children justified?

Abstract
In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
AuthorsH J van der Rhee, H H van Gelderen, M K Polano
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 60 Issue 3 Pg. 274-5 ( 1980) ISSN: 0001-5555 [Print] Sweden
PMID6158237 (Publication Type: Journal Article)
Chemical References
  • Tretinoin
  • Etretinate
Topics
  • Child
  • Dermatitis, Exfoliative (drug therapy)
  • Etretinate (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Male
  • Psoriasis (drug therapy)
  • Tretinoin (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: